Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma

Diseases of the Esophagus

Volumn 18, Issue 6, 2005, Pages 383-387

  Chaves, Paula ^a   Cruz, C ^a   Dias Pereira, A ^a   Suspiro, A ^a   de Almeida, J C M ^a   Leitao C N ^a   Soares, J ^a  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Apomucins; Barrett's adenocarcinoma; Barrett's esophagus; Differentiation; malignant transformation

Indexed keywords

MUCIN 2; MUCIN 5AC; MUCIN 6; APOMUCIN; MUCIN; STOMACH MUCIN; TUMOR MARKER;

ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CARCINOGENESIS; CELL HETEROGENEITY; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPIC BIOPSY; ESOPHAGOSCOPY; GOBLET CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; MALIGNANT TRANSFORMATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; TISSUE DIFFERENTIATION; TUMOR DIFFERENTIATION; ADENOCARCINOMA; BIOSYNTHESIS; CELL TRANSFORMATION; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS TUMOR; INTESTINE; METAPLASIA; PATHOLOGY; STOMACH MUCOSA;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; GASTRIC MUCIN; GASTRIC MUCOSA; GOBLET CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; METAPLASIA; MUCINS; TUMOR MARKERS, BIOLOGICAL;

EID: 33644824522     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2005.00520.x     Document Type: Article

References (27)

1. Haggitt R C. Barrett's esophagus, dysplasia and adenocarcinoma. Hum Patho 1994; 25: 982-93.
2. Hamilton S R, Smith R R L. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87: 301-12.
3. Mendes de Almeida J C, Chaves P, Dias Pereira A, Altorki N K. Is Barrett's oesophagus the precursor of most adenocarcinomas of the oesophagus and cardia? A biochemical study. Ann Surg 1997; 226: 725-33.
4. Sampliner R E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's oesophagus. Am J Gastroenterol 1998; 93: 1028-31.
5. Spechler J S, Goyal R K. The columnar-lined oesophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 1996; 110: 614-21.
6. Weinstein W M, Ippoliti A F. The diagnosis of Barrett's oesophagus: goblets, goblets, goblets. Gastrointestinal Endoscopy 1996; 1: 91-4.
7. Paull A, Trier J S, Dalton M D. The histologic spectrum of Barrett's oesophagus. N Engl J Med 1976; 295: 476-80.
8. Chandrasoma P T, Deer R, Dalton P et al. Distribution and significance of epithelial types in columnar-lined esophagus. Am J Surg Pathol 2001; 25: 1188-93.
9. Offner F A, Lewin K J, Weinstein W M. Metaplastic columnar cells in Barrett's oesophagus: A common and neglected cell type. Hum Pathol 1996; 27: 885-9.
10. Berenson M M, Herbst J J, Freston J W. Enzyme and ultrastructural characteristics of oesophageal columnar epithelium. Dig Dis 1974; 19: 895-907.
11. Zwas F, Shields H M, Doos W G et al. Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. Gastroenterology 1986; 90: 1932-41.
12. Mendes de Almeida J C, Rajasekaran A K, Godwin T, Quaroni A, Rodriguez-Boulan E, Altorki N K. Carcinoma of the cardia, Barrett's oesophagus and adenocarcinoma of the oesophagus and cardia ubiquitously express sucrase-isomaltase and crypt cell antigen. Dis Esoph 1996; 9: 191-7.
13. Chaves P, Cardoso P, Mendes de Almeida J C, Pereira A D, Leitão C N, Soares J. Non-goblet cell population of Barrett's oesophagus: An immunohistochemical demonstration of intestinal differentiation. Hum Pathol 1999; 30: 1291-5.
14. Neutra M R, Forstner J F. Gastrointestinal mucus: Synthesis secretion and function. In: Johnson L R, (ed.). Physiology of the Gastrointestinal Tract. New York: Raven 1987, 975-1009.
15. Chinyama C N, Marshall R E K, Owen W J et al. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: An immunopathological study with clinical correlation. Histopathology 1999; 35: 517-24.
16. Ho S B, Shekels L L, Toribara N W et al. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 1995; 55: 2681-90.
17. Reis C A, David L, Nielson P A et al. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 1997; 74: 112-21.
18. Arul G S, Moorghen M, Myerscough N et al. Mucin gene expression in Barrett's esophagus: An in situ hybridisation and immunohistochemical study. Gut 2000; 47: 753-61.
19. Guillem P, Billeret V, Buisine M P et al. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer 2000; 88: 856-61.
20. Jass J R, Walsh M D. Altered mucin expression in the gastrointestinal tract: A review. J Cell Mol Med 2001; 3: 327-51.
21. Barrett N R. Chronic peptic ulcer of the oesophagus and oesophagitis. Br J Surg 1950; 38: 175-82.
22. Barrett N R. The lower oesophagus lined by columnar epithelium. Surgery 1957; 41: 881-94.
23. Warson C, Van de Bovenkamp J H B, Korteland-Van Male A M et al. Barrett's esophagus is characterized by expression of gastric-type mucins (MUC5AC, MUC6) and TFF peptides (TFF1 and TFF2), but the risk of carcinoma development may be indicated by the intestinal type mucin MUC2. Hum Pathol 2002; 33: 660-8.
24. Van de Bovenkamp J H B, Korteland-Van Male A M, Warson C et al. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2. Histopathology 2003; 42: 555-65.
25. Chaves P, Cruz C, Cardoso P et al. Enterocytic columnar non-goblet cells of barrett's esophagus - an immunohistochemical demonstration of association with malignant evolution. J Exp Clin Cancer Res 2003; 22: 273-8.
26. Reis C A, David L, Correa P et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999; 59: 1003-7.
27. Glickman J N, Shahsafaei A, Odze R D. Mucin core peptide expression can help differentiate Barrett's esophagus from intestinal metaplasia of the stomach. Am J Surg Pathol 2003; 27: 1357-65.